HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 210 filers reported holding HORIZON PHARMA PLC in Q2 2015. The put-call ratio across all filers is 0.32 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $207,681,000 | +75.2% | 7,857,775 | +29.5% | 0.19% | +45.4% |
| Q4 2018 | $118,535,000 | +0.6% | 6,066,275 | +0.8% | 0.13% | +7.4% |
| Q3 2018 | $117,883,000 | -9.4% | 6,020,575 | -27.7% | 0.12% | +70.4% |
| Q2 2018 | $130,161,000 | +176.2% | 8,332,900 | +151.1% | 0.07% | +36.5% |
| Q1 2018 | $47,124,000 | +41.6% | 3,318,600 | +45.6% | 0.05% | +40.5% |
| Q4 2017 | $33,279,000 | +136.6% | 2,279,400 | +105.5% | 0.04% | +117.6% |
| Q3 2017 | $14,067,000 | +998.1% | 1,109,400 | +928.2% | 0.02% | +750.0% |
| Q2 2017 | $1,281,000 | -80.5% | 107,900 | -64.3% | 0.00% | -85.7% |
| Q4 2015 | $6,553,000 | -29.0% | 302,400 | -35.1% | 0.01% | -36.4% |
| Q3 2015 | $9,234,000 | -78.2% | 465,912 | -61.7% | 0.02% | -77.1% |
| Q2 2015 | $42,272,000 | +352.9% | 1,216,800 | +238.5% | 0.10% | +380.0% |
| Q1 2015 | $9,334,000 | – | 359,430 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Scale Management, LLC | 1,710,451 | $59,421,000 | 38.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 12,259,875 | $425,908,000 | 14.19% |
| Broadfin Capital, LLC | 4,815,807 | $167,301,000 | 8.99% |
| JW Asset Management, LLC | 766,724 | $26,636,000 | 8.10% |
| Marble Arch Investments | 1,888,000 | $65,589,000 | 5.65% |
| HealthCor Management, L.P. | 3,200,000 | $111,168,000 | 5.60% |
| Beach Point Capital Management LP | 794,290 | $27,594,000 | 5.42% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 3,325,829 | $115,539,000 | 4.52% |
| Ratan Capital Management LP | 1,321,300 | $45,902,000 | 4.37% |
| Green Owl Capital Management, LLC | 130,000 | $4,516,000 | 3.22% |